Literature DB >> 15330019

Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression.

Y Silbersack1, B M Taute, W Hein, H Podhaisky.   

Abstract

After total hip (THR) or knee replacement (TKR), there is still an appreciable risk of developing deep-vein thrombosis despite prophylaxis with low-molecular-weight heparin (LMWH). In a prospective, randomised study we examined the efficacy of LMWH in combination with intermittent pneumatic compression in patients undergoing primary unilateral THR or TKR. We administered 40 mg of enoxaparin daily to 131 patients combined with either the use of intermittent pneumatic compression or the wearing of graduated compression stockings. Compression ultrasonography showed no evidence of thrombosis after LMWH and intermittent pneumatic compression. In the group with LMWH and compression stockings the prevalence of thrombosis was 28.6% (40% after TKR, 14% after THR). This difference was significant (p < 0.0001). In the early post-operative phase after THR and TKR, combined prophylaxis with LMWH and intermittent pneumatic compression is more effective than LMWH used with graduated compression stockings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15330019     DOI: 10.1302/0301-620x.86b6.13958

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  19 in total

1.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Less deep vein thrombosis due to transcutaneous fibular nerve stimulation in total knee arthroplasty: a randomized controlled trial.

Authors:  Masashi Izumi; Masahiko Ikeuchi; Koji Aso; Natsuki Sugimura; Yuko Kamimoto; Tetsuya Mitani; Tadashi Ueta; Takayuki Sato; Masataka Yokoyama; Tetsuro Sugiura; Toshikazu Tani
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-24       Impact factor: 4.342

Review 4.  Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement.

Authors:  Jin Min Zhao; Mao Lin He; Zeng Ming Xiao; Ting Song Li; Hao Wu; Hua Jiang
Journal:  Cochrane Database Syst Rev       Date:  2014-12-22

Review 5.  A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.

Authors:  Sam Schulman; Ammar Majeed
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

Review 6.  Thromboprophylaxis in major knee and hip replacement surgery: a review.

Authors:  Gonzalo Eymin; Amir K Jaffer
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

7.  Thromboprophylaxis in radical retropubic prostatectomy: efficacy and patient compliance of a dual modality.

Authors:  Luca Cindolo; Luigi Salzano; Vincenzo Mirone; Ciro Imbimbo; Nicola Longo; Stavros K Kakkos; Daniel J Reddy
Journal:  Urol Int       Date:  2009-07-27       Impact factor: 2.089

8.  Thromboprophylaxis and orthopaedic surgery: options and current guidelines.

Authors:  Gandhi Nathan Solayar; Fintan John Shannon
Journal:  Malays J Med Sci       Date:  2014-05

9.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10

10.  On the design of a DEA-based device to pot entially assist lower leg disorders: an analytical and FEM investigation accounting for nonlinearities of the leg and device deformations.

Authors:  Shahram Pourazadi; Sadegh Ahmadi; Carlo Menon
Journal:  Biomed Eng Online       Date:  2015-11-05       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.